ArticleAddiction (Abingdon, England)2026

Experimental peptides, GLP-1s and polypharmacy: Future directions for image- and performance-enhancing drug harm reduction.

Luke A Turnock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.